These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15925704)

  • 1. Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition.
    Fugère M; Day R
    Trends Pharmacol Sci; 2005 Jun; 26(6):294-301. PubMed ID: 15925704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proprotein convertase inhibition: Paralyzing the cell's master switches.
    Klein-Szanto AJ; Bassi DE
    Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of proprotein convertases.
    Basak A
    J Mol Med (Berl); 2005 Nov; 83(11):844-55. PubMed ID: 16215768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cell-based sensor detecting the activity of individual basic proprotein convertases.
    Löw K; Hardes K; Fedeli C; Seidah NG; Constam DB; Pasquato A; Steinmetzer T; Roulin A; Kunz S
    FEBS J; 2019 Nov; 286(22):4597-4620. PubMed ID: 31276291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure and properties of proprotein convertase inhibitors].
    Kibirev VK; Osadchuk TV
    Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases.
    Bontemps Y; Scamuffa N; Calvo F; Khatib AM
    Med Res Rev; 2007 Sep; 27(5):631-48. PubMed ID: 17019676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enediynyl peptides and iso-coumarinyl methyl sulfones as inhibitors of proprotein convertases PCSK8/SKI-1/S1P and PCSK4/PC4: Design, synthesis and biological evaluations.
    Basak A; Goswami M; Rajkumar A; Mitra T; Majumdar S; O'Reilly P; Bdour HM; Trudeau VL; Basak A
    Bioorg Med Chem Lett; 2015; 25(10):2225-37. PubMed ID: 25881830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel circular, cyclic and acyclic Ψ(CH(2)O) containing peptide inhibitors of SKI-1/S1P: synthesis, kinetic and biochemical evaluations.
    Majumdar S; Chen A; Palmer-Smith H; Basak A
    Curr Med Chem; 2011; 18(18):2770-82. PubMed ID: 21568902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis.
    Stawowy P; Meyborg H; Stibenz D; Borges Pereira Stawowy N; Roser M; Thanabalasingam U; Veinot JP; Chrétien M; Seidah NG; Fleck E; Graf K
    Circulation; 2005 May; 111(21):2820-7. PubMed ID: 15911696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proprotein convertases are potential targets in the treatment of dyslipidemia.
    Seidah NG; Prat A
    J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitors.
    Lahlil R; Calvo F; Khatib AM
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):83-91. PubMed ID: 19149690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proprotein convertases, 20 years later.
    Seidah NG
    Methods Mol Biol; 2011; 768():23-57. PubMed ID: 21805237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proprotein convertases: lessons from knockouts.
    Scamuffa N; Calvo F; Chrétien M; Seidah NG; Khatib AM
    FASEB J; 2006 Oct; 20(12):1954-63. PubMed ID: 17012247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proprotein convertases - family of serine proteases with a broad spectrum of physiological functions].
    Małuch I; Walewska A; Sikorska E; Prahl A
    Postepy Biochem; 2016; 62(4):472-481. PubMed ID: 28132449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proprotein convertases as therapeutic targets.
    Chrétien M; Seidah NG; Basak A; Mbikay M
    Expert Opin Ther Targets; 2008 Oct; 12(10):1289-300. PubMed ID: 18781827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proprotein convertases furin and PC5: targeting atherosclerosis and restenosis at multiple levels.
    Stawowy P; Fleck E
    J Mol Med (Berl); 2005 Nov; 83(11):865-75. PubMed ID: 16244876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precursor convertases in the secretory pathway, cytosol and extracellular milieu.
    Seidah NG; Prat A
    Essays Biochem; 2002; 38():79-94. PubMed ID: 12463163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.
    Müller EJ; Caldelari R; Posthaus H
    J Mol Histol; 2004 Mar; 35(3):263-75. PubMed ID: 15339046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor screening of proprotein convertases using positional scanning libraries.
    Lindberg I; Appel JR
    Methods Mol Biol; 2011; 768():155-66. PubMed ID: 21805241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.
    Henrich S; Lindberg I; Bode W; Than ME
    J Mol Biol; 2005 Jan; 345(2):211-27. PubMed ID: 15571716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.